Acne conglobata and adalimumab: use of tumour necrosis factor‐α antagonists in treatment‐resistant acne conglobata, and review of the literature

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2230|40|4|383-386

ISSN： 0307-6938

Source： CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol.40, Iss.4, 2015-06, pp. : 383-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Pyoderma Vegetans Associated with Acne Conglobata

By  

THE JOURNAL OF DERMATOLOGY, Vol. 17, Iss. 7, 1990-07 ,pp. : 429-434

John Wiley & Sons Inc

Access to resources Recommend Favorite

The tumour necrosis factor‐α 308G>A genetic polymorphism may contribute to the pathogenesis of acne: a meta‐analysis

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 6, 2015-08 ,pp. : 682-687

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α antagonists as therapies for vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α antagonists as therapies for vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of long‐term treatment with tumour necrosis factor‐α inhibitors on single‐dose ultraviolet‐induced changes in human skin

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1762-1764

John Wiley & Sons Inc

Access to resources Recommend Favorite